The use of elevated doses of genistein-rich soy extract in the gene expression-targeted isoflavone therapy for sanfilippo disease patients

JIMD Reports

Volumn 5, Issue , 2012, Pages 21-25

  Malinová, Věra ^a   Węgrzyn, Grzegorz ^b   Narajczyk, Magdalena ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

Elevated dose; Hair morphology; Inherited metabolic disorder; Mucopolysaccharidosis type; Substrate reduction therapy

Indexed keywords

EID: 84885137965     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2011_87     Document Type: Chapter

References (18)

1. Arfi A, Richard M, Gandolphe C, Scherman D (2010) Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones. J Inherit Metab Dis 33:61–67
2. Beck M (2007) Mucopolysaccharidoses: clinical features and management. In: vom Dahl S, Wendel U, Strohmeyer G (eds) Genetic metabolic disorders: management, costs and sociomedical aspects.. Deutscher Arzte-Verlag, Cologne, pp 13–18
3. de Ruijter J, Valstar MJ, Wijburg FA (2011) Mucopolysaccharidosis type III (Sanfilippo syndrome): emerging treatment strategies. Curr Pharm Biotechnol 12(6):923–930
4. Delgadillo V, del Mar O’Callaghan M, Artuch R, Montero R, Pineda M (2011) Genistein supplementation in patients affected by Sanfilippo disease. J Inherit Metab Dis 34(5):1039–1044, doi:10.1007/s10545-011-9342-4
5. Friso A, Tomanin R, Salvalaio M, Scarpa M (2010) Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. Br J Pharmacol 159:1082–1091
6. Kloska A, Jakóbkiewicz-Banecka J, Narajczyk M, Banecka-Majkute-wicz Z, Węgrzyn G (2011) Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses. Metab Brain Dis 26:1–8
7. Malinowska M, Jakóbkiewicz-Banecka J, Kloska A, Tylki-Szymańska A, Czartoryska B, Piotrowska E, Wegrzyn A, Wegrzyn G (2008) Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses. Eur J Pediatr 167:203–209
8. Malinowska M, Wilkinson FL, Bennett W et al (2009) Genistein reduces lysosomal storage in peripheral tissues of mucopolysac-charide IIIB mice. Mol Genet Metab 98:235–242
9. Malinowska M, Wilkinson FL, Langford-Smith KJ et al (2010) Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One 5:e14192
10. Marucha J, Tylki-Szymańska A, Jakóbkiewicz-Banecka J, Piotrowska E, Kloska A, Czartoryska B, Węgrzyn G (2011) Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT). Am J Med Genet A 155A (9):2257–2262
11. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill Co., New York, pp 3421–3452
12. Piotrowska E, Jakobkiewicz-Banecka J, Baranska S et al (2006) Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 14:846–852
13. Piotrowska E, Jakobkiewicz-Banecka J, Tylki-Szymanska A et al (2008) Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients. Curr Ther Res Clin Exp 63:166–179
14. Piotrowska E, Jakóbkiewicz-Banecka J, Wegrzyn G (2010) Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy. Phytother Res 24(Suppl 1):S109–S113
15. Piotrowska E, Jakobkiewicz-Banecka J, Maryniak A, Tylki-Szymanska A, Puk E, Liberek A, Wegrzyn A, Czartoryska B, Slominska-Wojewodzka M, Wegrzyn G (2011) Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: Assessment of effects on cognitive functions and general status of patients. Med Sci Monit 17:CR196–CR202
16. Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 31:240–252
17. Wegrzyn G, Jakóbkiewicz-Banecka J, Narajczyk M, Wiśniewski A, Piotrowska E, Gabig-Cimińska M, Kloska A, Słomińska-Woje-wódzka M, Korzon-Burakowska A, Węgrzyn A (2010a) Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different. Med Hypoth 75:605–609
18. Wegrzyn G, Jakóbkiewicz-Banecka J, Gabig-Cimińska M, Piotrowska E, Narajczyk M, Kloska A, Malinowska M, Dziedzic D, Gołebiewska I, Moskot M, Wegrzyn A (2010b) Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochem Soc Trans 38:695–701